Presentation Information
[O40-02]Adverse effects of Selumetinib sulfate against plexiform neurofibromas in NF-1 patients
○Keiko Yanagihara1, Takuya Horibe1, Naoko Yamazaki1, Keisuke Oki1, Ken Nakajima1, Tomokazu Kimizu1, Yasuhito Tominaga1, Yukiko Mogami1, Maho Satoh2, Nobuhiko Okamoto3 (1.Department of Pediatric Neurology, Osaka Women's and Children's Hospital, 2.Department of Hematology/Oncology, Osaka Women's and Children's Hospital, 3.Department of Medical Genetics, Osaka Women's and Children's Hospital)